• 1
    Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 14636.
  • 2
    Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States [review]. Clin Immunol Immunopathol 1997; 84: 22343.
  • 3
    Svendsen AJ, Holm NV, Kyvik K, Petersen PH, Junker P. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ 2002; 324: 2646.
  • 4
    Dooley MA, Hogan SL. Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 2003; 15: 99103.
  • 5
    Olsson AR, Skogh T, Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004; 33: 3006.
  • 6
    Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus [review]. Autoimmunity 2006; 39: 6370.
  • 7
    Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St. Clair EW, et al. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte–associated antigen 4 genotype. Arthritis Rheum 2005; 52: 114859.
  • 8
    Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AA, Walker JG, MacFarlane JG, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 2001; 31: 2209.
  • 9
    Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, et al. A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004; 77: 106.
  • 10
    Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002; 59: 5459.
  • 11
    Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Male systemic sclerosis and occupational silica exposure: a population-based study. Aust N Z J Med 2000; 30: 21520.
  • 12
    Bovenzi M, Barbone F, Pisa FE, Della Vedova A, Betta A, Romeo L, et al. Scleroderma and occupational risk factors: a case-control study. G Ital Med Lav Ergon 2003; 25 Suppl: 467.
  • 13
    Parks CG, Cooper GS, Nylander-French LA, Hoppin JA, Sanderson WT, Dement JM. Comparing questionnaire-based methods to assess occupational silica exposure. Epidemiology 2004; 15: 43341.
  • 14
    Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus [review]. Curr Rheumatol Rep 2004; 6: 36774.
  • 15
    Costallat L, De Capitani EM, Zambon L. Pulmonary silicosis and systemic lupus erythematosus in men: a report of two cases. Joint Bone Spine 2002; 69: 6871.
  • 16
    Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60: 1229.
  • 17
    Steenland K, Sanderson W, Calvert GM. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 2001; 12: 40512.
  • 18
    Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107 Suppl 5: 793802.
  • 19
    Radon K, Windstetter D, Solfrank S, von Mutius E, Nowak D, Schwarz HP. Exposure to farming environments in early life and type 1 diabetes: a case-control study. Diabetes 2005; 54: 32126.
  • 20
    Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002; 2: 30313.
  • 21
    Rosenberg AM, Semchuk KM, McDuffie HH, Ledingham DL, Cordeiro DM, Cessna AJ, et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A 1999; 57: 22536.
  • 22
    De Roos AJ, Cooper GS, Alavanja MC, Sandler DP. Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 2005; 15: 76270.
  • 23
    Walsh SJ, DeChello LM. Excess autoimmune disease mortality among school teachers. J Rheumatol 2001; 28: 153745.
  • 24
    Cooper GS, Parks CG, Treadwell EL, St.Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004; 31: 192833.
  • 25
    Maitre A, Hours M, Bonneterre V, Arnaud J, Arslan MT, Carpentier P, et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 2004; 31: 2395401.
  • 26
    Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992; 51: 13224.
  • 27
    Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998; 41: 11118.
  • 28
    Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S. Occupation, occupational exposure to chemicals and rheumatological disease: a register based cohort study. Scand J Rheumatol 1994; 23: 30510.
  • 29
    Arnett FC, Fritzler MJ, Ahn C, Holian A. Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin). J Rheumatol 2000; 27: 40510.
  • 30
    Burnett C, Maurer J, Rosenberg HM, Dosemeci M. Mortality by occupation, industry, and cause of death: 24 reporting states, 1984–1988. Cincinnati (OH): Department of Health and Human Services (US); 1997. National Institute for Occupational Safety and Health (NIOSH) publication 97114.
  • 31
    NIOSH Safety and health topic: national occupational mortality surveillance. Overview of the NOMS system. Online at URL:
  • 32
    United States Bureau of the Census. 1980 census of population: alphabetical index of industries and occupations. Washington, DC: US government Printing Office, 1980.
  • 33
    Green L. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep 1970; 85: 81527.
  • 34
    Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology (Oxford) 2006; 45 Suppl 3: iii34.
  • 35
    Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort. J Am Med Womens Assoc 1998; 53: 912.
  • 36
    Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 2005; 48: 6377.
  • 37
    McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond) 2005; 55: 7987.
  • 38
    Forand SP. Leukaemia incidence among workers in the shoe and boot manufacturing industry: a case-control study. Environ Health 2004; 3: 7.
  • 39
    Milham S. Mortality experience of the AFL-CIO United Brotherhood of Carpenters and Joiners of America. Department of Health, Education and Welfare; 1974. National Institute for Occupational Safety and Health (NIOSH) publication 74129.
  • 40
    Turner DW, Schumacher MC, West DW. Comparison of occupational interview data to death certificate data in Utah. Am J Ind Med 1987; 12: 14551.
  • 41
    Milham S Jr. Mortality in aluminum reduction plant workers. J Occup Med 1979; 21: 47580.
  • 42
    Zandman-Goddard G, Shoenfeld Y. Infections and SLE [review]. Autoimmunity 2005; 38: 47385.
  • 43
    Bach JF. Infections and autoimmune diseases. J Autoimmun 2005; 25 Suppl: 7480.
  • 44
    Olsson AR, Skogh T, Wingren G. Occupational determinants for rheumatoid arthritis. Scand J Work Environ Health 2000; 26: 2439.
  • 45
    Olsson AR, Skogh T, Axelson O, Wingren G. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med 2004; 61: 2338.
  • 46
    Reckner OA, Skogh T, Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 9349.
  • 47
    Stopford CM, Stopford W. Potential for respirable quartz exposure from North Carolina farm soils. Scand J Work Environ Health 1995; 21 Suppl 2: 446.
  • 48
    Noonan CW, Pfau JC, Larson TC, Spence MR. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 2006; 114: 12437.
  • 49
    Calvo-Alen J, Alarcon GS, Campbell R Jr, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford) 2005; 44: 11869.